FindMyKOL
Clinical trialNCT01466946CompletedObservational

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

NCT01466946 is an observational study sponsored by Memorial Sloan Kettering Cancer Center. As of 21 Nov 2026, it is completed. It studies Lung Cancer. The registry lists an enrollment of 25 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2011 and a primary completion date of 29 Feb 2016.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01466946
FieldValue
Registry IDNCT01466946
StatusCompleted
Study typeObservational study
Lead sponsorMemorial Sloan Kettering Cancer Center
Enrollment25
Registered sites1
Countries1
ConditionsLung Cancer
Start30 Nov 2011
Primary completion29 Feb 2016
Study completion29 Feb 2016
Last update posted11 Feb 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • Memorial Sloan Kettering Cancer Center

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01466946

Each answer restates registry values shown on this page.

What is NCT01466946?

NCT01466946 is an observational study sponsored by Memorial Sloan Kettering Cancer Center. It studies Lung Cancer.

Who leads NCT01466946?

The registry names William Alago, MD (principal investigator, Memorial Sloan Kettering Cancer Center) as the overall official.

Where does NCT01466946 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01466946 end?

The registry lists a primary completion date of 29 Feb 2016 and a study completion date of 29 Feb 2016. The sponsor last updated the record on 11 Feb 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.